pasireotide pamoate · Recordati Rare · NDA 203255
Signifor Lar Kit
Earliest generic entry, as listed · earliest of 5 marketed strengths
23 May 2028
Blocked by patent: US 9351923.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9351923 | product | 23 May 2028 |
| US 7473761 | substance, product | 14 Dec 2026 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 5
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 203255 · 001 · RLD | for suspension, intramuscular | EQ 20MG BASE/VIAL | 23 May 2028 |
| 203255 · 002 · RLD | for suspension, intramuscular | EQ 40MG BASE/VIAL | 23 May 2028 |
| 203255 · 003 · RLD | for suspension, intramuscular | EQ 60MG BASE/VIAL | 23 May 2028 |
| 203255 · 004 · RLD | for suspension, intramuscular | EQ 10MG BASE/VIAL | 23 May 2028 |
| 203255 · 005 · RLD | for suspension, intramuscular | EQ 30MG BASE/VIAL | 23 May 2028 |
Expired or delisted (1)
- US 7759308 · product · 25 Oct 2026